Shopping Cart
- Remove All
Your shopping cart is currently empty
ZINC00640089 is a selective lipid carrier protein-2 (LCN2) inhibitor. ZINC00640089 inhibited cell proliferation and cell viability, and reduced AKT phosphorylation in SUM149 cells. ZINC00640089 can be used to study inflammatory breast cancer (IBC).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $60 | In Stock | |
| 5 mg | $147 | In Stock | |
| 10 mg | $198 | In Stock | |
| 25 mg | $328 | In Stock | |
| 50 mg | $455 | In Stock | |
| 100 mg | $619 | In Stock |
| Description | ZINC00640089 is a selective lipid carrier protein-2 (LCN2) inhibitor. ZINC00640089 inhibited cell proliferation and cell viability, and reduced AKT phosphorylation in SUM149 cells. ZINC00640089 can be used to study inflammatory breast cancer (IBC). |
| In vitro | In SUM149 cells, ZINC00640089 (0.01-100 µM; 72 h) decreases cell proliferation and cell viability [1]. Additionally, ZINC00640089 (1, 10 µM; 15 min, 1 h) reduces the levels of p-Akt in SUM149 cells [1]. |
| Molecular Weight | 370.32 |
| Formula | C20H13F3N2O2 |
| Cas No. | 667880-11-7 |
| Smiles | C(C(NC1=C(C(F)(F)F)C=CC=C1)=O)N2C=3C4=C(C2=O)C=CC=C4C=CC3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 26.67 mg/mL (72.01 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.